US Patent 10570169 Conjugated antisense compounds and their use
Patent 10570169 was granted and assigned to Ionis Pharmaceuticals on February, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 30 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 11 Dec, 2023
Golden AI
Edits made to:
Article (+203 characters)
Article
Patent abstract
Provided herein are oligomeric compounds with conjugate groups. In certain embodiments, the gomeric compounds are conjugated to N-Acetylgalactosamine or to N-Acetylgalactosamine analogues.
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Eric E. Swayze0
Michael T. Migawa0
Punit P. Seth0
Thazha P. Prakash0
Edits on 1 Feb, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
105701690
Date of Patent
February 25, 2020
0Patent Application Number
153114360
Date Filed
May 21, 2015
0Patent Primary Examiner
Edits on 1 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10570169 Conjugated antisense compounds and their use
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10570169
Date of patent
February 25, 2020
Patent application number
15311436
Date Filed
May 21, 2015
Patent primary examiner
Find more entities like US Patent 10570169 Conjugated antisense compounds and their use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
